Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 2CRSI S.A AL2SI 24. avr 2025 3.90 +3.17   
 74Software 74SW 24. avr 2025 30.50 +0.66   
 Ab Science AB 24. avr 2025 1.47 +3.37   
 ABC Arbitrage ABCA 24. avr 2025 5.96 +0.34   
 ABEO SA ABEO 24. avr 2025 9.40 -0.63   
 Abionyx Pharma ABNX 24. avr 2025 1.21 -1.31   
 Abivax ABVX 24. avr 2025 6.12 +1.32   
 Acanthe Developpement SA ACAN 24. avr 2025 0.32 +1.06   
 Accor SA AC 24. avr 2025 40.66 +0.15   
 Acheter-Louer.FR ALALO 24. avr 2025 0.00 +25.00   
 Acteos EOS 24. avr 2025 1.03 -3.67   
 Actia Group ALATI 24. avr 2025 2.90 +1.40   
 Activium Group MLACT 24. avr 2025 1.22 0.00   
 Adeunis ALARF 24. avr 2025 0.60 +10.00   
 Adocia ADOC 24. avr 2025 3.88 -2.76   
 Adomos ALADO 24. avr 2025 0.08 -3.20   
 Adux ALDUX 24. avr 2025 1.62 -0.92   
 Advicenne ALDVI 24. avr 2025 1.71 -1.72   
 Advini ALAVI 24. avr 2025 13.20 +0.38   
 Aelis Farma S.A. AELIS 24. avr 2025 1.19 +2.15   
 Aerkomm Inc AKOM 24. avr 2025 2.80 0.00   
 Aeroports de Paris SA ADP 24. avr 2025 107.00 +1.71   
 Affluent Medical AFME 24. avr 2025 1.35 -1.46   
 Afyren ALAFY 24. avr 2025 1.68 +0.60   
 Agripower France SA ALAGP 24. avr 2025 0.95 0.00   
 AgroGeneration ALAGR 24. avr 2025 0.06 -4.29   
 Air France-KLM AF 24. avr 2025 7.59 -1.30   
 Air Liquide AI 24. avr 2025 178.58 +2.22   
 Airbus SE AIR 24. avr 2025 137.26 -1.14   
 Akwel AKW 24. avr 2025 7.46 -1.58   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.